Investor Relations
Tools
Interview with Robert S. Weiss,
President and CEO of
The Cooper Companies, Inc.
Conducted by CEOCFO Magazine
February 2012

Investor Relations

Investors > Investor Relations

The Cooper Companies, Inc. (Cooper) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,000 employees with products sold in over 100 countries.

CooperVision is one of the world's leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism, presbyopia and ocular dryness; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

Contact lenses are medical devices and can only be prescribed and dispensed by a licensed eye care professional.

CooperSurgical is the leading company dedicated to providing medical devices and procedure solutions that improve healthcare delivery to women regardless of clinical setting. CooperSurgical is fostering that position through expansion of its core businesses and introduction of advanced technology-based products which aid clinicians in the management and treatment of commonly seen conditions. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Clinic. Its customers are healthcare professionals and institutions providing care to and for women. For more information, visit www.coopersurgical.com.


View all »Upcoming Events & Presentations

Jun 7, 2012 at 5:00 PM ET
The Cooper Companies Second Quarter 2012 Earnings

View all »   RSSRecent Press Releases

May 2, 2012
The Cooper Companies Announces Release Date for Second Quarter 2012

Apr 5, 2012
The Cooper Companies Announces Its Subsidiary CooperVision Has Received FDA Special 510(K) Clearance on Its Avaira Toric Contact Lenses


Investor Presentation Company Factsheet


Investor Sheet Financial Results